抗炎症薬の世界市場レポート 2025年

抗炎症薬市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.8％で2,288億3,000万米ドルに成長します。予測期間における成長の原動力は、自己免疫疾患の罹患率の上昇、個別化医療に対する需要の高まり、高齢者の増加、政府の支援策、局所療法や標的療法に対する嗜好の高まりにあるとみられます。この期間に予想される主要動向には、生物製剤の革新、生物製剤とバイオシミラーへのシフト、遠隔医療ベースの配合の増加、創薬における人工知能の統合、新規抗炎症メカニズムの研究開発の進行、標的抗炎症療法の進歩などがあります。

関節炎の有病率の増加は、今後数年間の抗炎症薬市場の成長を促進すると予想されます。関節炎は、1つまたは複数の関節の炎症によって特徴付けられ、痛み、腫れ、こわばりを引き起こし、加齢とともに悪化することが多いです。関節炎の開発は、人口の高齢化が主要原因であり、時間の経過に伴う関節の自然な磨耗や損傷が、この症状の発症リスクを高めるからです。抗炎症薬は、関節炎を管理する上で重要な役割を担っており、関節の炎症や疼痛を軽減し、患者が可動性を維持し、日常生活をより快適に行えるよう支援し、全体的な生活の質を向上させます。例えば、2023年3月、英国政府機関であるOffice for Health Improvement and Disparitiesは、2022年には16歳以上の17.6％が関節炎や持続的な関節や背中の問題などの長期的な筋骨格系（MSK）疾患を有しており、2021年の17.0％から増加していると報告しました。このように、関節炎の有病率の上昇が抗炎症薬市場の成長に大きく寄与しています。

抗炎症薬市場の主要企業は、標的薬剤送達を改善し患者のコンプライアンスを高めるため、外用液剤などの革新的な製剤の開発に注力しています。外用液とは、皮膚や患部に直接塗布する液状の薬剤のことで、全身的な副作用を最小限に抑えながら、有効成分を炎症部位に局所的に作用させることができます。例えば、2022年12月、インドの製薬会社ルピン・リミテッドは、米国ホライゾン・ファーマ・セラピューティクスのペンサイド（ジクロフェナクナトリウム外用液、2％w/w）の正規ジェネリック医薬品を発売しました。これは、ルピンの米国におけるジェネリック医薬品のポートフォリオを拡大し、手頃な価格の抗炎症治療へのアクセスを改善することを目的としています。同剤は非ステロイド性抗炎症薬で、変形性膝関節症による疼痛を緩和するために使用され、局所的な塗布により局所的な緩和をもたらし、経口非ステロイド性抗炎症薬に伴う全身的なリスクを軽減します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の抗炎症薬：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の抗炎症薬市場：成長率分析
• 世界の抗炎症薬市場の実績：規模と成長、2019～2024年
• 世界の抗炎症薬市場の予測：規模と成長、2024～2029年、2034年
• 世界の抗炎症薬：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の抗炎症薬市場：薬剤クラス別、実績と予測、2019～2024年、2024～2029年、2034年
• ステロイド
• 非ステロイド性抗炎症薬（NSAIDs）
• 生物製剤とバイオシミラー
• その他の薬剤クラス
• 世界の抗炎症薬市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 非経口
• 経口
• 局所
• 吸入
• 世界の抗炎症薬市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 自己免疫疾患
• 呼吸器疾患
• その他
• 世界の抗炎症薬市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の抗炎症薬市場、ステロイドのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• コルチコステロイド
• ミネラルコルチコイド
• 世界の抗炎症薬市場、非ステロイド性抗炎症薬（NSAIDs）のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 非選択的非ステロイド性抗炎症薬（NSAIDs）
• 選択的シクロオキシゲナーゼ-2（COX-2）阻害剤
• 世界の抗炎症薬市場、バイオ医薬品とバイオシミラーのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 腫瘍壊死因子（TNF）阻害剤
• インターロイキン（IL）阻害剤
• ヤヌスキナーゼ（JAK）阻害剤
• 世界の抗炎症薬市場、その他の薬剤クラスのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 疾患修飾性抗リウマチ薬（DMARD）
• 免疫抑制剤
• 抗ヒスタミン薬

第7章 地域別・国別分析

• 世界の抗炎症薬市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の抗炎症薬市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 抗炎症薬市場：競合情勢
• 抗炎症薬市場：企業プロファイル
  • Merck & Co. Inc.
  • AbbVie Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.

第31章 その他の大手企業と革新的企業

• Bristol-Myers Squibb Company
• AstraZeneca plc
• Gilead Sciences Inc.
• Amgen Inc.
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Vertex Pharmaceuticals Inc.
• UCB S.A.
• Sun Pharmaceutical Industries Ltd.
• Aurobindo Pharma Limited
• Dr. Reddy's Laboratories
• Cipla Limited
• Cadila Pharmaceuticals
• Samsung Bioepis
• Lupin Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 抗炎症薬市場、2029年：新たな機会を提供する国
• 抗炎症薬市場、2029年：新たな機会を提供するセグメント
• 抗炎症薬市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Anti-inflammatory drugs are a category of medications designed to alleviate inflammation, pain, fever, and swelling by disrupting the body's natural inflammatory processes. They function by blocking the activity or production of chemical messengers like prostaglandins, leukotrienes, and cytokines, which play key roles in initiating and maintaining inflammation.

The primary classes of anti-inflammatory drugs include steroids, nonsteroidal anti-inflammatory drugs (NSAIDs), biologics and biosimilars, among others. Steroids, which imitate natural hormones, are commonly used to manage conditions such as asthma, arthritis, and allergies. These medications can be administered in various forms, including parenteral, oral, topical, and inhalation routes. They are employed in the treatment of multiple conditions, including autoimmune and respiratory diseases. Anti-inflammatory drugs are distributed through several channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The anti-inflammatory drugs market research report is one of a series of new reports from The Business Research Company that provides anti-inflammatory drugs market statistics, including anti-inflammatory drugs industry global market size, regional shares, competitors with the anti-inflammatory drugs market share, anti-inflammatory drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the anti-inflammatory drugs industry. This anti-inflammatory drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-inflammatory drugs market size has grown rapidly in recent years. It will grow from $136.86 billion in 2024 to $152.08 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. Growth during the historic period can be attributed to several key factors, including an aging population, the increasing prevalence of chronic inflammatory diseases, greater over-the-counter availability of medications, rising awareness of pain management, and the expansion of healthcare infrastructure.

The anti-inflammatory drugs market size is expected to see rapid growth in the next few years. It will grow to $228.83 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. Growth in the forecast period is expected to be driven by the rising incidence of autoimmune diseases, increasing demand for personalized medicine, a growing geriatric population, supportive government initiatives, and a rising preference for topical and targeted therapies. Key trends anticipated during this period include innovations in biologic drugs, a shift toward biologics and biosimilars, the rise of telemedicine-based prescriptions, the integration of artificial intelligence in drug discovery, ongoing research and development of novel anti-inflammatory mechanisms, and advancements in targeted anti-inflammatory therapies.

The increasing prevalence of arthritis is expected to drive the growth of the anti-inflammatory drugs market in the coming years. Arthritis is characterized by inflammation in one or more joints, leading to pain, swelling, and stiffness that often worsens with age. The growing incidence of arthritis is largely attributed to aging populations, as the natural wear and tear on joints over time raises the risk of developing the condition. Anti-inflammatory drugs play a key role in managing arthritis by reducing joint inflammation and pain, helping patients maintain mobility, perform daily activities more comfortably, and improve their overall quality of life. For example, in March 2023, the Office for Health Improvement and Disparities, a UK government department, reported that in 2022, 17.6% of individuals aged 16 and above had a long-term musculoskeletal (MSK) condition-such as arthritis or persistent joint or back issues-an increase from 17.0% in 2021. Thus, the rising prevalence of arthritis is contributing significantly to the growth of the anti-inflammatory drugs market.

Leading companies in the anti-inflammatory drugs market are focusing on developing innovative formulations, such as topical solutions, to improve targeted drug delivery and enhance patient compliance. A topical solution is a liquid form of medication applied directly to the skin or affected area, allowing the active ingredients to act locally at the site of inflammation while minimizing systemic side effects. For example, in December 2022, Lupin Limited, an India-based pharmaceutical company, launched the authorized generic version of PENNSAID (Diclofenac Sodium Topical Solution, 2% w/w) from Horizon Pharma Therapeutics in the United States. This move aimed to expand Lupin's U.S. generics portfolio and improve access to affordable anti-inflammatory treatments. The drug, a nonsteroidal anti-inflammatory agent, is used to relieve pain caused by osteoarthritis of the knee, offering localized relief through topical application and reducing the systemic risks associated with oral NSAIDs.

In March 2022, Pfizer, a U.S.-based pharmaceutical company, acquired Arena Pharmaceuticals for approximately $6.7 billion. This acquisition was intended to strengthen Pfizer's pipeline of potential therapies targeting immuno-inflammatory diseases, with a focus on areas such as gastroenterology, dermatology, and cardiology. Arena Pharmaceuticals, also based in the U.S., is a clinical-stage company dedicated to developing innovative treatments for a range of immuno-inflammatory conditions.

Major players in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited.

North America was the largest region in the anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in anti-inflammatory drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the anti-inflammatory drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anti-inflammatory drugs market consists of sales of immunosuppressants, COX-2 inhibitors, interleukin inhibitors, and TNF-alpha inhibitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anti-Inflammatory Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anti-inflammatory drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anti-inflammatory drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-inflammatory drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Steroids; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Biologics And Biosimilars; Other Drug Classes
• 2) By Route of Administration: Parenteral; Oral; Topical; Inhalation
• 3) By Applications: Autoimmune Diseases; Respiratory Diseases; Other Diseases
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• Subsegments:
• 1) By Steroids: Corticosteroids; Mineralocorticoids
• 2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Selective Cyclooxygenase-2 (COX-2) Inhibitors
• 3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin (IL) Inhibitors; Janus Kinase (JAK) Inhibitors; Other Biologics And Biosimilars
• 4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs); Immunosuppressants; Antihistamines
• Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anti-Inflammatory Drugs Market Characteristics

3. Anti-Inflammatory Drugs Market Trends And Strategies

4. Anti-Inflammatory Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Anti-Inflammatory Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Anti-Inflammatory Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Anti-Inflammatory Drugs Market Growth Rate Analysis
• 5.4. Global Anti-Inflammatory Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Anti-Inflammatory Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Anti-Inflammatory Drugs Total Addressable Market (TAM)

6. Anti-Inflammatory Drugs Market Segmentation

• 6.1. Global Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Steroids
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Biologics And Biosimilars
• Other Drug Classes
• 6.2. Global Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral
• Oral
• Topical
• Inhalation
• 6.3. Global Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autoimmune Diseases
• Respiratory Diseases
• Other Diseases
• 6.4. Global Anti-Inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.5. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Mineralocorticoids
• 6.6. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Selective Cyclooxygenase-2 (COX-2) Inhibitors
• 6.7. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Biologics And Biosimilars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tumor Necrosis Factor (TNF) Inhibitors
• Interleukin (IL) Inhibitors
• Janus Kinase (JAK) Inhibitors
• 6.8. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
• Immunosuppressants
• Antihistamines

7. Anti-Inflammatory Drugs Market Regional And Country Analysis

• 7.1. Global Anti-Inflammatory Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Anti-Inflammatory Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anti-Inflammatory Drugs Market

• 8.1. Asia-Pacific Anti-Inflammatory Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anti-Inflammatory Drugs Market

• 9.1. China Anti-Inflammatory Drugs Market Overview
• 9.2. China Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anti-Inflammatory Drugs Market

• 10.1. India Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anti-Inflammatory Drugs Market

• 11.1. Japan Anti-Inflammatory Drugs Market Overview
• 11.2. Japan Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anti-Inflammatory Drugs Market

• 12.1. Australia Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anti-Inflammatory Drugs Market

• 13.1. Indonesia Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anti-Inflammatory Drugs Market

• 14.1. South Korea Anti-Inflammatory Drugs Market Overview
• 14.2. South Korea Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anti-Inflammatory Drugs Market

• 15.1. Western Europe Anti-Inflammatory Drugs Market Overview
• 15.2. Western Europe Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anti-Inflammatory Drugs Market

• 16.1. UK Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anti-Inflammatory Drugs Market

• 17.1. Germany Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anti-Inflammatory Drugs Market

• 18.1. France Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anti-Inflammatory Drugs Market

• 19.1. Italy Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anti-Inflammatory Drugs Market

• 20.1. Spain Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anti-Inflammatory Drugs Market

• 21.1. Eastern Europe Anti-Inflammatory Drugs Market Overview
• 21.2. Eastern Europe Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anti-Inflammatory Drugs Market

• 22.1. Russia Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anti-Inflammatory Drugs Market

• 23.1. North America Anti-Inflammatory Drugs Market Overview
• 23.2. North America Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anti-Inflammatory Drugs Market

• 24.1. USA Anti-Inflammatory Drugs Market Overview
• 24.2. USA Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anti-Inflammatory Drugs Market

• 25.1. Canada Anti-Inflammatory Drugs Market Overview
• 25.2. Canada Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anti-Inflammatory Drugs Market

• 26.1. South America Anti-Inflammatory Drugs Market Overview
• 26.2. South America Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anti-Inflammatory Drugs Market

• 27.1. Brazil Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anti-Inflammatory Drugs Market

• 28.1. Middle East Anti-Inflammatory Drugs Market Overview
• 28.2. Middle East Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anti-Inflammatory Drugs Market

• 29.1. Africa Anti-Inflammatory Drugs Market Overview
• 29.2. Africa Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anti-Inflammatory Drugs Market Competitive Landscape And Company Profiles

• 30.1. Anti-Inflammatory Drugs Market Competitive Landscape
• 30.2. Anti-Inflammatory Drugs Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Anti-Inflammatory Drugs Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. AstraZeneca plc
• 31.3. Gilead Sciences Inc.
• 31.4. Amgen Inc.
• 31.5. Regeneron Pharmaceuticals Inc.
• 31.6. Biogen Inc.
• 31.7. Vertex Pharmaceuticals Inc.
• 31.8. UCB S.A.
• 31.9. Sun Pharmaceutical Industries Ltd.
• 31.10. Aurobindo Pharma Limited
• 31.11. Dr. Reddy's Laboratories
• 31.12. Cipla Limited
• 31.13. Cadila Pharmaceuticals
• 31.14. Samsung Bioepis
• 31.15. Lupin Limited

32. Global Anti-Inflammatory Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anti-Inflammatory Drugs Market

34. Recent Developments In The Anti-Inflammatory Drugs Market

35. Anti-Inflammatory Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Anti-Inflammatory Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Anti-Inflammatory Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Anti-Inflammatory Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer